Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1537-1540

  Jiao, Hong ^a   Wang, Weizhi ^a   Wang, Huabing ^b   Wu, Yun ^a   Wang, Lihua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphism; Guillain Barr syndrome; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GUILLAIN BARRE SYNDROME; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; ASIAN; CHINA; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860317121     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0892-1     Document Type: Article

References (30)

1. Hughes RA, Hadden RD, Gregson NA et al (1999) Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 100:74-97 (Pubitemid 30038241)
2. Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758-765 (Pubitemid 32240096)
3. Griffin JW, Li CY, Ho TW et al (1996) Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol 39:17-28
4. Prasad KN, Nyati KK, Verma A et al (2010) Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barre syndrome. Hum Immunol 71:905-910
5. Ho TW, Mishu B, Li CY et al (1995) Guillain-Barre syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118(Pt 3):597-605
6. Huang S, Li L, Liang S et al (2009) Conversion of peripheral CD4(?)CD25(-) T cells to CD4(?)CD25(?) regulatory T cells by IFN-gamma in patients with Guillain-Barre syndrome. J Neu-roimmunol 217:80-84
7. Chi LJ, Wang HB, Zhang Y et al (2007) Abnormality of circulating CD4(?)CD25(?) regulatory T cell in patients with Guil-lain-Barre syndrome. J Neuroimmunol 192:206-214 (Pubitemid 350213129)
8. Anderson GM, Nakada MT, DeWitte M (2004) Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4:314-320 (Pubitemid 38987055)
9. Hajeer AH, Hutchinson IV (2000) TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 50:216-228 (Pubitemid 30610098)
10. Hajeer AH, Hutchinson IV (2001) Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 62:1191-1199 (Pubitemid 33032271)
11. Wilson AG, di Giovine FS, Blakemore AI et al (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353
12. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 27(Suppl):S21-S24 (Pubitemid 20178648)
13. Hadden RD, Cornblath DR, Hughes RA et al (1998) Electro-physiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 44:780-788 (Pubitemid 28516049)
14. Zhang J, Dong H, Li B et al (2007) Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome. Eur Neurol 58:21-25 (Pubitemid 47038156)
15. Sinha S, Prasad KN, Jain D et al (2010) Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome. Acta Neurol Scand 122:21-26
16. Nyati KK, Prasad KN, Verma A et al (2010) Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in Northern Indian population. J Neuroimmunol 218: 116-119
17. Geleijns K, Emonts M, Laman JD et al (2007) Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome. J Neuroimmunol 190:127-130 (Pubitemid 47625600)
18. van Sorge NM, van der Pol WL, Jansen MD et al (2005) Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol 162:157-164
19. Myhr KM, Vagnes KS, Maroy TH et al (2003) Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome. J Neuroimmunol 139:81-83 (Pubitemid 36694393)
20. Gao J, Shan G, Sun B et al (2006) Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis. Thorax 61:466-471 (Pubitemid 43901514)
21. Li N, Zhou Z, Liu X et al (2008) Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: a meta-analysis. Clin Biochem 41:881-886
22. Ristic S, Lovrecic L, Starcevic-Cizmarevic N et al (2007) Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur Neurol 57:203-207 (Pubitemid 46701476)
23. Drulovic J, Popadic D, Mesaros S et al (2003) Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis. Eur Neurol 50:25-29 (Pubitemid 36736966)
24. Jenkins HG, Ikeda H (1992) Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci 108:99-104
25. Redford EJ, Hall SM, Smith KJ (1995) Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118(Pt 4):869-878
26. Sharief MK, McLean B, Thompson EJ (1993) Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome. Ann Neurol 33:591-596 (Pubitemid 23161879)
27. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399 (Pubitemid 27368335)
28. Abraham LJ, Kroeger KM (1999) Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562-566 (Pubitemid 29489880)
29. Gonzalez S, Rodrigo L, Martinez-Borra J et al (2003) TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients withfistulizing disease. Am J Gastroenterol 98:1101-1106 (Pubitemid 36733773)
30. Ho SY, Wang YJ, Chen HL et al (2004) Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15:657-663